March 3, 2026

Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block

Key Points

High sensitivity of the AmoyDx PLC panel offers reliable detection of NSCLC.
The study emphasizes using pleural effusion cell blocks when biopsies are not feasible.
Specimens with low tumor cell content still demonstrate efficacy in detection.
Supporting non-invasive diagnostic options for advanced lung cancer treatment planning.

Abstract

Pleural effusion cell blocks are a practical and reliable alternative for molecular testing of advanced NSCLC when biopsy is not feasible. The high sensitivity of the AmoyDx PLC panel even for specimens with low tumor cell content underscores its potential clinical utility.

Bookmark

Cite This Study

Murakami et al. (Wed,) studied this question.

synapsesocial.com/papers/69a75b42c6e9836116a22498 https://doi.org/https://doi.org/10.1093/jjco/hyag003

Bookmark